Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression (Q35170212)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression |
scientific article |
Statements
1 reference
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression (English)
1 reference
Prajnan Das
1 reference
James L Abbruzzese
1 reference
Jason B Fleming
1 reference
Christopher H Crane
1 reference
Gauri R Varadhachary
1 reference
John S Yordy
1 reference
Gregg A Staerkel
1 reference
Milind M Javle
1 reference
Howard Safran
1 reference
Waqar Haque
1 reference
Bridgett D Hobbs
1 reference
Sunil Krishnan
1 reference
Jeffrey E Lee
1 reference
Robert A Wolff
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference